ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

34,272Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 457

$1.53M Total Retail Price of All Prescriptions

Rank: 17 out of 457

861 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 861 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 29,759 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,623 1,395 1 2
OMEPRAZOLE 1,618 1,443 2 1
LISINOPRIL 1,367 1,148 3 3
LEVOTHYROXINE SODIUM 1,025 880 4 5
AMLODIPINE BESYLATE 984 846 5 4
METOPROLOL TARTRATE 924 798 6 7
FUROSEMIDE 887 805 7 10
IBUPROFEN 723 572 8 14
LACTULOSE 718 632 9 78
POTASSIUM CHLORIDE 691 627 10 28
LANTUS 582 488 11 56
CLOPIDOGREL 549 509 12 19
MEGESTROL ACETATE 542 507 R 10 13 94
METFORMIN HCL 521 407 14 6
SILVER SULFADIAZINE 478 464 10 15 127
DONEPEZIL HCL 437 432 16 22
RANITIDINE HCL 419 375 17 17
FAMOTIDINE 417 331 18 62
TAMSULOSIN HCL 403 388 19 36
CARVEDILOL 393 364 20 20
BUMETANIDE 373 360 21 123
HYDROCHLOROTHIAZIDE 372 325 22 8
SSD 359 354 10 23 158
MUPIROCIN 357 310 24 91
CRESTOR 339 269 25 9
SURE COMFORT 326 255 10 26 103
METOCLOPRAMIDE HCL 318 249 27 116
PLAVIX 317 290 28 24
CARBIDOPA-LEVODOPA 315 313 29 128
INSULIN SYRINGE 313 252 30 79
ATENOLOL 300 261 31 11
NOVOLIN 70-30 300 246 31 113
AMMONIUM LACTATE 297 290 33 82
GABAPENTIN 295 259 34 15
NEXIUM 293 243 35 12
GLYBURIDE 280 224 R 36 64
DIGOXIN 279 275 37 69
KETOCONAZOLE 275 235 38 92
ENALAPRIL MALEATE 274 200 39 35
LIDODERM 248 216 40 31
LOSARTAN POTASSIUM 246 227 41 18
NAMENDA 236 236 42 32
MELOXICAM 229 198 43 41
MECLIZINE HCL 228 226 44 55
DIOVAN 225 198 45 30
NOVOLIN R 215 185 46 147
ADVAIR DISKUS 204 164 47 27
SINGULAIR 180 137 48 43
TRAMADOL HCL 177 146 49 26
METOPROLOL SUCCINATE 169 133 50 21
PANTOPRAZOLE SODIUM 169 155 50 59
GLIPIZIDE 164 137 52 42
AZITHROMYCIN 153 135 53 44
VOLTAREN 150 145 54 34
LEVETIRACETAM 149 130 55 160
PHENYTOIN SODIUM EXTENDED 141 119 56 171
SUCRALFATE 138 117 57 163
ALENDRONATE SODIUM 135 126 58 16
SPIRONOLACTONE 131 127 59 124
MONTELUKAST SODIUM 129 106 60 86
CIPROFLOXACIN HCL 128 118 61 71
RISPERIDONE 125 90 62 102
ZAFIRLUKAST 123 120 63 213
WARFARIN SODIUM 119 110 64 38
PROAIR HFA 111 61 65 66
FLUTICASONE PROPIONATE 110 103 66 40
CLOTRIMAZOLE-BETAMETHASONE 109 105 67 60
LATANOPROST 107 95 68 198
DICYCLOMINE HCL 107 86 68 115
DICLOFENAC SODIUM 104 82 70 49
DOXAZOSIN MESYLATE 103 102 71 73
GLIMEPIRIDE 101 83 72 75
FINASTERIDE 99 99 73 85
CLOTRIMAZOLE 99 69 73 207
AMIODARONE HCL 97 97 75 286
SPIRIVA 96 87 76 101
NIFEDIPINE ER 95 84 77 89
DESONIDE 93 81 78 331
TRICOR 92 62 79 83
CITALOPRAM HBR 92 71 79 45
NYSTATIN 92 87 79 234
CLONIDINE HCL 91 76 82 52
SELENIUM SULFIDE 85 82 83 277
ACTOS 83 55 84 105
DILTIAZEM HCL 80 80 85 260
ISOSORBIDE MONONITRATE ER 79 64 86 84
GEMFIBROZIL 75 50 87 112
QUETIAPINE FUMARATE 74 69 88 109
RESTASIS 74 68 88 175
ATORVASTATIN CALCIUM 73 67 90 33
AGGRENOX 72 72 91 210
ALBUTEROL SULFATE 70 43 92 151
PATANOL 68 56 93 224
DIOVAN HCT 68 67 93 51
EASY TOUCH 67 64 95 231
CLOBETASOL PROPIONATE 65 63 96 125
NAPROXEN 63 56 97 65
ZOLPIDEM TARTRATE 63 48 97 13
CHOLESTYRAMINE 63 56 97 327
PENTOXIFYLLINE 62 57 100 67
LABETALOL HCL 62 47 100 215
LOVASTATIN 61 61 102 25
TIMOLOL MALEATE 61 48 102 326
BENZTROPINE MESYLATE 60 23 R 104 171
VESICARE 59 58 105 173
OXYBUTYNIN CHLORIDE 59 59 105 142
GLIPIZIDE XL 58 46 107 159
DIVALPROEX SODIUM 58 45 107 177
SERTRALINE HCL 58 30 107 57
POLYETHYLENE GLYCOL 3350 57 48 110 187
COMBIVENT 56 35 111 133
PREDNISONE 56 44 111 95
NITROGLYCERIN PATCH 55 51 113 157
CILOSTAZOL 55 50 113 88
LEVOFLOXACIN 55 53 113 131
THEOPHYLLINE ANHYDROUS 54 41 116 244
LANSOPRAZOLE 54 43 116 74
HYDROXYZINE HCL 53 52 R 118 199
HUMULIN 70-30 53 36 118 203
CICLOPIROX 53 49 118 126
FENOFIBRATE 53 36 118 46
TRAZODONE HCL 52 38 122 104
TEKTURNA 51 39 123 211
NOVOLOG MIX 70-30 50 40 124 190
LOVAZA 50 45 124 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 48 124 153
BACLOFEN 50 46 124 141
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.